Showing results (1-10 of 195) with videos related to
Sort By:
Pageof 20
Clinical Pharmacokinetics|June 1, 1996
Clinically important drug interactions with anticoagulants. An updateS Harder, P ThürmannPharmacoeconomics|April 7, 1996
Criteria for the appropriate drug utilisation of immunoglobulinP Thürmann, S HarderInternational Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
Concentration/effect relationship of bunazosin, a selective alpha 1-adrenoceptor antagonist in hypertensive patients after single and multiple oral dosesS Harder, P ThürmannArzneimittel-Forschung|February 1, 1994
Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trialS Harder, S Rietbrock, P ThürmannInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
Concentration/effect analysis of verapamil: evaluation of different approachesS Harder, S Rietbrock, P ThürmannAmerican Journal of Therapeutics|August 1, 1994
Concentration/Effect Analysis of Antihypertensive DrugsS. Harder, P. Thürmann, N. RietbrockMedizinische Klinik (Munich, Germany : 1983)|April 18, 1998
[Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy]S Harder, P Thürmann, A SteioffArzneimittel-Forschung|January 1, 1992
[Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms]P G Merz, P Thürmann, S HarderEuropean Journal of Clinical Pharmacology|January 1, 1995
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)P Thürmann, S Harder, C M KirchmaierEuropean Journal of Clinical Pharmacology|January 1, 1991
Prescription of drugs not listed in a clinic's pharmacopoeia: supervision by clinical pharmacologistsS Harder, P Thürmann, T Huber, et al.Pageof 20